Dr. Samuel Morris Brown, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5121 S Cottonwood St, Murray, UT 84107 Phone: 801-507-6415 |
George E. Thomsen, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 5169 Cottonwood St, Murray, UT 84107 Phone: 801-507-7000 |
Dr. Rasheel Chowdhary, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5979 S Fashion Blvd, Murray, UT 84107 Phone: 801-263-2370 |
Dr. Timothy Ronald Leclair, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5121 S Cottonwood St, Murray, UT 84107 Phone: 801-507-4627 |
Devin Davis, Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 5169 S Cottonwood St Ste 640, Murray, UT 84107 Phone: 801-507-3600 |
Dr. Lynette Mardel Brown, M.D., PH.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5121 S. Cottonwood Suite 307, Intermountain Medical Center, Murray, UT 84157 Phone: 801-507-3378 Fax: 801-507-3375 |
News Archive
Data presented today at the EULAR 2011 Annual Congress demonstrated that initial treatment with adalimumab (Humira, ADA) plus methotrexate in early RA patients can provide high levels of disease control in many patients, and may also offer the opportunity to change future treatment options for some.
Wearables have proliferated in the marketplace, but there's still a lot of opportunity for growth. One of the ways in which wearables are limited is that people expect their wearables to really measure what they feel is important to be measured
Billing and insurance paperwork consume at least one out of every five dollars of private insurance health spending in California, according to a new study by health policy researchers.
The U.S. Food and Drug Administration (FDA) has approved a Mexican-made drug that is the first specific treatment for stings by the most common type of scorpion in the United States. The new preparation called Anascorp is found to have few allergic reactions and was approved after a series of clinical trials by the University of Arizona.
› Verified 4 days ago